Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Fluorescence Polarization Immunoassay, Tobramycin

FDA product code LFW · 10 cleared devices

Class 2 Clinical Toxicology
Regulation
21 CFR 862.3900
Review panel
TX
Implant
No
Life sustaining
No
Third party review
Yes
GMP exempt
No
Clearance span
1984-05-31 – 1997-02-04
↑